Citius Oncology Inc.

NASDAQ: CTOR · Real-Time Price · USD
1.72
0.02 (1.18%)
At close: Aug 20, 2025, 10:05 AM

Citius Oncology Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022
Net Income
-21.15M -12.7M -5.43M
Depreciation & Amortization
n/a n/a n/a
Stock-Based Compensation
7.5M 1.97M n/a
Other Working Capital
12.91M 8.61M 4.74M
Other Non-Cash Items
n/a -601.3K -47.97K
Deferred Income Tax
576K 576K 576K
Change in Working Capital
13.2M 10.16M 4.86M
Operating Cash Flow
126.35K -601.3K -47.97K
Capital Expenditures
-5M 4.00 n/a
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
n/a -1.32M -67.32M
Sales Maturities Of Investments
n/a n/a n/a
Other Investing Acitivies
-5M n/a n/a
Investing Cash Flow
-5M -1.32M -67.32M
Debt Repayment
3.8M n/a n/a
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
1.07M 1.66M -383.84K
Financial Cash Flow
4.87M 1.66M 67.66M
Net Cash Flow
112.00 -256.43K 289.18K
Free Cash Flow
-4.87M -601.3K -47.97K